Drug Profile
Epinephrine inhalation - Alkermes
Alternative Names: AIR EpinephrineLatest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator Alkermes
- Class Anti-infectives; Antiallergics; Antiasthmatics; Bronchodilators; Catecholamines; Ethanolamines; Skin disorder therapies; Small molecules
- Mechanism of Action Adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anaphylaxis
Most Recent Events
- 31 May 2006 This compound is still in active development
- 16 Mar 2004 Data presented at the 60th American Academy of Allergy, Asthma and Immunology (AAAAI-2004) conference have been added to the pharmacokinetics and pharmacodynamics section
- 31 Aug 2003 Phase-I clinical trials in Anaphylaxis in USA (Inhalation)